Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys

Fuwa M., Shimazaki A., Odani-Kawabata N., Kirihara T., Taniguchi T., Iwamura R., Yoneda K., Kato M., Morishima K., Shams N.K.

2021
Journal of Ocular Pharmacology and Therapeutics

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Fuwa, M., Product Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; Shimazaki, A., Product Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; Odani-Kawabata, N., Product Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan, Product Development Division, Santen Inc., Emeryville, CA, United States; Kirihara, T., Ophthalmology Innovation Center, Santen Pharmaceutical Co. Ltd., Osaka, Japan; Taniguchi, T., Ophthalmology Innovation Center, Santen Pharmaceutical Co. Ltd., Osaka, Japan; Iwamura, R., Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan; Yoneda, K., Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan; Kato, M., Product Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; Morishima, K., Product Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; Shams, N.K., Product Development Division, Santen Inc., Emeryville, CA, United States, Ophthalmology Innovation Center, Santen Inc., Emeryville, CA, United States

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A Three-year Prospective Study

Akagi T.; Fukuchi T.; Higashide T.; Udagawa S.; Ohkubo S.; Sugiyama K.; Tanihara H.; Araie M.; Tomita G.; Matsumoto C.; Tomidokoro A.; Hangai M.; Kawata H.; Inai M.; Tanaka Y.; SVF Prospector Study Group

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study

Takada N.; Ishikawa M.; Sato K.; Kunikata H.; Ninomiya T.; Hanyuda A.; Fukuda E.; Yamaguchi K.; Ono C.; Kirihara T.; Shintani C.; Tsusu C.; Osanai A.; Goshima N.; Izumi Y.; Zorumski C.F.; Nakazawa T.

Bioequivalence of Preservative-free and Preserved Omidenepag Isopropyl (OMDI) 0.002% Ophthalmic Solutions in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Results from the Phase 3 DAISY Study

Aihara M.; Lu F.; Ikeda T.; Odani-Kawabata N.